Document is current
Any future updates will be listed below
-
Authors
Darzi, Andrea J.
Busse, Jason W.
Torabiardakani, Kian
Phillips, Mark https://orcid.org/0000-0003-0923-261X
Thabane, Lehana
Bhandari, Mohit
Borrelli, Enrico https://orcid.org/0000-0003-2815-5031
Steel, David H.
Wykoff, Charles C. https://orcid.org/0000-0001-7756-5091
Chaudhary, Varun https://orcid.org/0000-0002-9988-4146
,
Bhandari, Mohit
Sivaprasad, Sobha
Thabane, Lehana
Kaiser, Peter
Sarraf, David
Bakri, Sophie J.
Garg, Sunir J.
Singh, Rishi P.
Holz, Frank G.
Wong, Tien Y.
Guymer, Robyn H.
Sadda, SriniVas R.
- License Information
-
More Information
Article History
Received: 26 November 2024
Revised: 2 December 2024
Accepted: 12 December 2024
First Online: 18 December 2024
Competing interests
: AJD: none. JWB: none. KT: none. MP: none. LT: none. MB: none. EB: none. DHS: Consultant: Gyroscope, Roche, Alcon, BVI; Research funds: Alcon, Bayer, DORC, Gyrsocope, Boehringer-Ingelheim. CW: Dr. Wykoff reported consulting for 4DMT, AbbVie, Adverum, Alcon, Alimera, Alkeus, Annexon, Apellis, Aviceda, Bayer, Biocryst, Boehringer Ingelheim, Clearside, EyeBiotech, EyePoint, Genentech, InGel, Janssen, Kiora, KodiakMerck, Neurotech, Novartis, Ocuphire, ONL, Opthea, Osanni, Panther, Perceive Bio, Ray, Regeneron, RegenXBio, Sanofi, Santen, Stealth, Valo, Zeiss. VC: Dr. Chaudhary reports acting as an advisory board member, grants and other from Novartis; acting as an advisory board member, grants and other from Bayer; acting as an advisory board member and grants from Roche; acting as an advisory board member for Alcon; acting as an advisory board member for Apellis; and acting as an advisory board member for Boehringer Ingelheim outside the submitted work. VC is also a current member of the Eye editorial board.
Free to read: This content has been made available to all.
